Publications

5600 Results

Alliance A021602: Phase III, Double Blinded Study of Cabozantinib Versus Placebo for Advanced Neuroendocrine Tumors (NET) After Progression on Prior Therapy (CABINET)

Authors
J Chan;S Geyer;F Ou;M Knopp;S Behr;T Zemla;A Jacoba;A Shergill;E Wolin;T Halfdanarson;N Trikalinos;B Konda;N Vijayvergia;N Dasari;N Dasari;J Strosberg;E Kohn;M Kulke;E O'Reilly;J Meyerhardt
Journal / Conference
Annals of Oncology VOLUME 34, SUPPLEMENT 2, S1292; ESMO (October 20-24, 2023, Madrid, Spain), proferred paper presentation
Year
2023
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/A021602

PAPMET2 A Phase II Randomized Trial of Cabozantinib with or without Atezolizumab in Patients with Advanced Papillary Renal Cell Carcinoma (PRCC): SWOG S2200)

Authors
B Maughan;M Plets;S Pal;Y Ged;C Tangen;U Vaishampayan;SP Lerner;IM Thompson
Journal / Conference
IKCS North America (Nov 9-11, 2023, Nashville, TN), TIP poster
Year
2023
Research Committee(s)
Genitourinary
Study Number(s)
S2200

Impact of Dexamethasone (Dex) Dose Strength on Outcomes in Newly Diagnosed Multiple Myeloma (NDMM): A Secondary Analysis of SWOG Studies S0777 and S1211

Authors
R Banerjee;R Sexton;A Cowan;S Ailawadhi;V Rajkumar;S Kunnathu Kumar;S Lonial;B Barlogie;BGM Durie;S Usmani;A Hoering;R Orlowski
Journal / Conference
ASH Annual Meeting (Dec9-12,2023, San Diego, CA), oral
Year
2023
Research Committee(s)
Myeloma
Study Number(s)
S0777, S1211

Randomized, Phase III Study of Early Intervention with Venetoclax and Obinutuzumab versus Delayed Therapy with Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): EVOLVE CLL/SLL Study (SWOG S1925; NCT#04269902)

Authors
D Stephens;A Moseley;B Hill;M Shadman;M Fisch;A Danilov;D Ng;L Roeker;D Brander;V Banerji;M Othus;S O'Brien;H Erba
Journal / Conference
IWCLL (October 6-9, 2023, Boston, MA), TIP poster
Year
2023
Research Committee(s)
Leukemia
Study Number(s)
S1925

Intra-tumoral cell neighborhoods coordinate outcomes in pancreatic ductal adenocarcinoma

Authors
M Wattenberg;S Colby;I Garrido-Laguna;Y Xue;R Chang;D Delman;M Beg;A Wang-Gillam;J Wade;K Guthrie;EG Chiorean;S Ahmad;A Lowy;PA Philip;D Sohal;G Beatty
Journal / Conference
Gastroenterology Jan 18:S0016-5085(24)00049-0. doi: 10.1053/j.gastro.2024.01.013. Online ahead of print
Year
2023
Research Committee(s)
Gastrointestinal
PMID
PMID38244727
Study Number(s)
S1505

Sponsors’ Perspectives on the Impact of the COVID-19 Public Health Emergency on Interventional Cancer Clinical Trial Protocols and Data Quality

Authors
J Unger;H Stires;L Levit;M Stewart;B McKelvey;B Canin;N Connelly;E Dressler;K Flaherty;P Fredette;L Jones;P McCann;T Miller;A Ontilio;F Palmieri;T Patel;R Paul;G Smith;S Bruinooge;E Garrett-Mayer;X Lei;A Alva;C Schenkel
Journal / Conference
JCO Oncol Pract Oct;19(10):907-916
Year
2023
Research Committee(s)
Cancer Care Delivery
PMID
PMID37643386
PMC
PMC10615547

Evaluating the Utility and Privacy of Synthetic Breast Cancer Clinical Trial Data Sets

Authors
S El Kababji;N Mitsakakis;X Fang;A Beltran-Bless;G Pond;L Vandermeer;D Radhakrishnan;L Mosquera;A Paterson;L Shepherd;B Chen;W Barlow;J Gralow;M Savard;M Clemons;K El Emam
Journal / Conference
JCO Clinical Cancer Informatics Sep;7:e2300116. doi: 10.1200/CCI.23.00116
Year
2023
Research Committee(s)
Breast
PMID
PMID38011617
PMC
PMC10703127
Study Number(s)
S0307

DEVELOPMENT AND TESTING OF A CUSTOM NANOSTRING RNA CODESET FOR MUSCLE-INVASIVE BLADDER CANCER UTILIZING TCGA SUBTYPING (SWOG S1011)

Authors
SR Patel;M Anurag;MS Lucia;J Meeks;D McConkey;J Kim;C Tangen;S Lerner
Journal / Conference
SUO (Society of Urologic Oncology) (Nov 28-Dec 1, Washington, DC), poster #73
Year
2023
Research Committee(s)
Genitourinary
Study Number(s)
S1011

Association of Serum Carotenoids and Retinoids with Intraprostatic Inflammation in Men without Prostate Cancer or Clinical Indication for Biopsy in the Placebo Arm of the Prostate Cancer Prevention Trial

Authors
S Chadid;X Song;J Schenk;B Gurel;MS Lucia;I Thompson, Jr.;M Neuhouser;P Goodman;H Parnes;S Lippman;W Nelson;A De Marzo;E Platz
Journal / Conference
Nutrition and Cancer 74(1):141-148
Year
2022
Research Committee(s)
Cancer Control
PMID
PMID33511883
PMC
PMC8319215
Study Number(s)
SWOG-9217

Genome-wide association studies of survival in 1,520 cancer patients treated with bevacizumab-containing regimens

Authors
J Quintanilha;J Wang;A Sibley;W Xu;O Espin-Garcia;C Jiang;A Etheridge;M Ratain;H-J Lenz;M Bertagnolli;H Kindler;M Dickler;A Venook;J Liu;K Owzar;D Lin;F Innocenti
Journal / Conference
International Journal of Cancer, Jan 15;150(2):279-289. doi: 10.1002/ijc.33810. Epub 2021 Oct 5
Year
2022
Research Committee(s)
Breast and Gastrointestinal
PMID
PMID34528705
Study Number(s)
CTSU/C40503, CTSU/C80405